Phase I trial of temozolomide (CCRG 81045: M&B 39831: NSC 362856).

Phase I trial of temozolomide (CCRG 81045: M&B 39831: NSC 362856).

Temozolomide (CCRG 81045: M&B 39831: NSC 362856) is an analogue of mitozolomide displaying similar broad spectrum activity in mouse tumours, but showing considerably less myelosuppression in the toxicology screen. Temozolomide was initially studied intravenously at doses between 50-200 mg m-2 an...

Full description

Bibliographic Details
Main Authors:	Newlands, E. S., Blackledge, G. R., Slack, J. A., Rustin, G. J., Smith, D. B., Stuart, N. S., Quarterman, C. P., Hoffman, R., Stevens, M. F., Brampton, M. H.
Format:	Online
Language:	English
Published:	1992
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977719/

Similar Items

Antitumour imidazotetrazines--XI: Effect of 8-carbamoyl-3-methylimidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one [CCRG 81045; M and B 39831 NSC 362856] on poly(ADP-ribose) metabolism.
by: Tisdale, M. J.
Published: (1985)

Phase I trial of elactocin.
by: Newlands, E. S., et al.
Published: (1996)

Phase II trial of temozolomide in low-grade non-Hodgkin's lymphoma.
by: Woll, P. J., et al.
Published: (1995)

O6-methylguanine-DNA methyltransferase in pretreatment tumour biopsies as a predictor of response to temozolomide in melanoma.
by: Middleton, M. R., et al.
Published: (1998)

Cabaran NSC
by: Utusan Malaysia,
Published: (2016)

Prevention of multidrug resistance (MDR) in osteosarcoma by NSC23925
by: Yang, X, et al.
Published: (2014)

Phase I-II study of carboplatin vincristine methotrexate and bleomycin (COMB) in carcinoma of the cervix.
by: Rustin, G. J., et al.
Published: (1988)

Activity of GR30921X (NSC 382057) and GR63178A (NSC D611615) in human ovarian cancer lines.
by: Boven, E., et al.
Published: (1990)

O6-benzylguanine enhances the sensitivity of a glioma xenograft with low O6-alkylguanine-DNA alkyltransferase activity to temozolomide and BCNU.
by: Wedge, S. R., et al.
Published: (1996)

Potentiation of temozolomide and BCNU cytotoxicity by O(6)-benzylguanine: a comparative study in vitro.
by: Wedge, S. R., et al.
Published: (1996)

Ivan eyes NSC series no.1 title
by: The Star,
Published: (2013)

Robust phenotyping strategies for evaluation of stem non-structural carbohydrates (NSC) in rice
by: Wang, Diane R., et al.
Published: (2016)

WRN-targeted therapy using inhibitors NSC 19630 and NSC 617145 induce apoptosis in HTLV-1-transformed adult T-cell leukemia cells
by: Moles, R., et al.
Published: (2016)

3-aminobenzamide and/or O6-benzylguanine evaluated as an adjuvant to temozolomide or BCNU treatment in cell lines of variable mismatch repair status and O6-alkylguanine-DNA alkyltransferase activity.
by: Wedge, S. R., et al.
Published: (1996)

Depletion of O6-alkylguanine-DNA alkyltransferase correlates with potentiation of temozolomide and CCNU toxicity in human tumour cells.
by: Baer, J. C., et al.
Published: (1993)

NSC the last hopeL NSAM trying to salvage careers of four shooters
by: Singh, Ajitpal
Published: (2017)

Role of NSC319726 in ovarian cancer based on the bioinformatics analyses
by: Xue, Ji, et al.
Published: (2015)

Anti-tumour activity of flavone acetic acid (NSC 347512) in mice--influence of immune status.
by: Bibby, M. C., et al.
Published: (1991)

NSC666715 and Its Analogs Inhibit Strand-Displacement Activity of DNA Polymerase β and Potentiate Temozolomide-Induced DNA Damage, Senescence and Apoptosis in Colorectal Cancer Cells
by: Jaiswal, Aruna S., et al.
Published: (2015)

Response to flavone acetic acid (NSC 347512) of primary and metastatic human colorectal carcinoma xenografts.
by: Giavazzi, R., et al.
Published: (1988)

In vitro and in vivo studies on the combination of Brequinar sodium (DUP-785; NSC 368390) with 5-fluorouracil; effects of uridine.
by: Peters, G. J., et al.
Published: (1992)

Predicting response to chemotherapy for patients with epithelial ovarian cancer using urinary polyamine excretion patterns.
by: Lawton, F. G., et al.
Published: (1990)

Temozolomide for the treatment of metastatic melanoma
by: Quirbt, I., et al.
Published: (2007)

Response of chemically induced primary colon tumours of the mouse to flavone acetic acid (NSC 347 512).
by: Pratesi, G., et al.
Published: (1988)

The HIF-pathway inhibitor NSC-134754 induces metabolic changes and anti-tumour activity while maintaining vascular function
by: Baker, L C J, et al.
Published: (2012)

NSC-87877 inhibits DUSP26 function in neuroblastoma resulting in p53-mediated apoptosis
by: Shi, Y, et al.
Published: (2015)

A negative phase II trial methylene dimethane sulphonate in advanced ovarian cancer (Cancer Research Campaign Phase I/II Trials Committee).
by: Smith, D. B., et al.
Published: (1988)

The effect of intensity of administered treatment on the outcome of germ cell tumours treated with POMB/ACE chemotherapy.
by: Crawford, S. M., et al.
Published: (1989)

Chemotherapy of advanced malignant teratomas.
by: Newlands, E. S., et al.
Published: (1980)

Temozolomide in aggressive pituitary adenomas and carcinomas
by: Ortiz, Leon D., et al.
Published: (2012)

Dose-dense Temozolomide: Is It Still Promising?
by: NAGANE, Motoo
Published: (2015)

Accelerated hyperfractionation plus temozolomide in glioblastoma
by: Kaul, David, et al.
Published: (2016)

The Synergistic Effect of Combination Progesterone and Temozolomide on Human Glioblastoma Cells
by: Atif, Fahim, et al.
Published: (2015)

Cytotoxic properties of a 4-nitroimidazole (NSC 38087): a radiosensitizer of hypoxic cells in vitro.
by: Stratford, I. J., et al.
Published: (1981)

Pharmacokinetics and tolerability of NSC23925b, a novel P-glycoprotein inhibitor: preclinical study in mice and rats
by: Gao, Yan, et al.
Published: (2016)

A phase II trial of lomeguatrib and temozolomide in metastatic colorectal cancer
by: Khan, O A, et al.
Published: (2009)

Unique chemosensitivity of MAC 16 tumours to flavone acetic acid (LM975, NSC 347512).
by: Bibby, M. C., et al.
Published: (1988)

Zhodnocení vlivu koroze žárově zinkované oceli na soudržnost hladkých prutů s betonem třídy „NSC“
by: Pokorný P., et al.
Published: (2015-07-01)

Response of differentiated but not anaplastic teratoma to interferon.
by: Rustin, G. J., et al.
Published: (1984)

NSC-34 Motor Neuron-Like Cells Are Unsuitable as Experimental Model for Glutamate-Mediated Excitotoxicity
by: Madji Hounoum, Blandine, et al.
Published: (2016)